Cristina Larkin
Chief Operating Officer, Spero Therapeutics, Inc.
Companies
- Spero Therapeutics, Inc.Chief operating officer Nov 1, 2017 to Feb 3, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Spero Therapeutics, Inc. SPRO63,581 shares2$72.5K at $1.14Feb 1, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 1, 2022Granted 38,014 shares of Spero Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2